Display options
Share it on

Infect Immun. 2000 Jun;68(6):3448-54. doi: 10.1128/IAI.68.6.3448-3454.2000.

Immune response against a cross-reactive epitope on the heat shock protein 60 homologue of Helicobacter pylori.

Infection and immunity

H Yamaguchi, T Osaki, M Kai, H Taguchi, S Kamiya

Affiliations

  1. Department of Microbiology, Kyorin University School of Medicine, Mitaka, Japan. [email protected]

PMID: 10816497 PMCID: PMC97622 DOI: 10.1128/IAI.68.6.3448-3454.2000

Abstract

We previously established a monoclonal antibody (MAb), designated H9, which reacts with the heat shock protein 60 (HSP60) homologue of Helicobacter pylori as well as with other bacterial and human HSP60s. To determine the importance of a cross-reactive epitope on H. pylori HSP60 in H. pylori immunopathogenesis, we performed (i) mapping of an epitope on H. pylori HSP60 recognized by the H9 MAb, (ii) analysis of immunoglobulin G responses of patients with or without H. pylori infection to its epitope region, and (iii) studies of the protective effect of immunization with its epitope region on H. pylori infection in mice. The epitope recognized by the H9 MAb was mapped to the sequence of amino acids 189 to 203 (VEGMQFDRGYLSPYF) on the H. pylori HSP60 molecule. It was confirmed that the synthesized peptide designated pH9 was recognized by the H9 MAb. Enzyme-linked immunosorbent assay analysis showed that patients with H. pylori infection (n = 349) had significantly lower titers of pH9 antibody than did uninfected patients (n = 200) (P < 0.001), but this was not the case with purified H. pylori HSP60 recombinant Escherichia coli GroEL, or recombinant human HSP60. In C57BL/6 mice immunized with the pH9 peptide with Freund's complete adjuvant (FCA), the number of H. pylori organisms colonizing the stomach was significantly lower than that in mice immunized with pCont plus FCA (P < 0.0001) or FCA only (P < 0.005). The results suggest that the immune response to the cross-reactive epitope (pH9 region) on H. pylori HSP60 is unique and might be associated with protection against H. pylori infection.

References

  1. Proc Natl Acad Sci U S A. 1979 Sep;76(9):4350-4 - PubMed
  2. Mol Microbiol. 1994 Nov;14(4):691-703 - PubMed
  3. Nature. 1988 May 26;333(6171):330-4 - PubMed
  4. J Med Microbiol. 1988 Jun;26(2):93-9 - PubMed
  5. Infect Immun. 1988 Nov;56(11):2896-906 - PubMed
  6. Infect Immun. 1989 Apr;57(4):1119-25 - PubMed
  7. Mol Cell Biol. 1989 May;9(5):2279-83 - PubMed
  8. Curr Top Microbiol Immunol. 1990;155:125-41 - PubMed
  9. Nature. 1970 Aug 15;227(5259):680-5 - PubMed
  10. J Biol Chem. 1990 Jun 5;265(16):9464-9 - PubMed
  11. Science. 1990 Jul 6;249(4964):67-9 - PubMed
  12. Infect Immun. 1990 Oct;58(10):3380-7 - PubMed
  13. N Engl J Med. 1991 Apr 11;324(15):1043-8 - PubMed
  14. J Immunol. 1991 Jul 1;147(1):285-91 - PubMed
  15. Nature. 1991 Jul 4;352(6330):17-8 - PubMed
  16. Gastroenterology. 1991 Aug;101(2):437-45 - PubMed
  17. Semin Cell Biol. 1990 Feb;1(1):1-9 - PubMed
  18. Semin Cell Biol. 1990 Feb;1(1):27-35 - PubMed
  19. Infect Immun. 1991 Sep;59(9):3219-26 - PubMed
  20. N Engl J Med. 1991 Oct 17;325(16):1127-31 - PubMed
  21. Gastroenterology. 1992 Feb;102(2):720-7 - PubMed
  22. Infect Immun. 1992 May;60(5):1883-9 - PubMed
  23. Infect Immun. 1992 May;60(5):2125-7 - PubMed
  24. Infect Immun. 1992 Sep;60(9):3658-63 - PubMed
  25. Infect Immun. 1993 Mar;61(3):1117-20 - PubMed
  26. J Clin Invest. 1993 Feb;91(2):717-23 - PubMed
  27. Eur J Gastroenterol Hepatol. 1994 Dec;6 Suppl 1:S23-7 - PubMed
  28. Proc Natl Acad Sci U S A. 1995 Jul 3;92(14):6499-503 - PubMed
  29. Clin Diagn Lab Immunol. 1994 May;1(3):325-9 - PubMed
  30. Infect Immun. 1996 Mar;64(3):905-12 - PubMed
  31. Infect Immun. 1996 Jun;64(6):2031-40 - PubMed
  32. Infect Immun. 1996 Jul;64(7):2643-8 - PubMed
  33. J Med Microbiol. 1996 Oct;45(4):270-7 - PubMed
  34. Proc Natl Acad Sci U S A. 1996 Dec 10;93(25):14648-53 - PubMed
  35. Clin Diagn Lab Immunol. 1997 Jul;4(4):440-6 - PubMed
  36. J Med Microbiol. 1997 Oct;46(10):819-24 - PubMed
  37. J Med Microbiol. 1997 Oct;46(10):825-31 - PubMed
  38. Infect Immun. 1998 Mar;66(3):1023-7 - PubMed
  39. Microbiol Immunol. 1997;41(12):909-16 - PubMed
  40. Infect Immun. 1998 Jun;66(6):2705-12 - PubMed
  41. J Exp Med. 1998 Dec 21;188(12):2277-88 - PubMed
  42. Cell Immunol. 1999 Jan 10;191(1):74-80 - PubMed
  43. Infect Immun. 1993 May;61(5):1601-10 - PubMed
  44. Mol Microbiol. 1993 Aug;9(3):645-52 - PubMed
  45. Gastroenterology. 1993 Nov;105(5):1431-40 - PubMed
  46. Scand J Gastroenterol. 1993 Dec;28(12):1105-11 - PubMed
  47. N Engl J Med. 1994 May 5;330(18):1267-71 - PubMed
  48. Res Microbiol. 1993 Nov-Dec;144(9):691-701 - PubMed
  49. Infect Immun. 1994 Jul;62(7):2784-91 - PubMed
  50. Infect Immun. 1994 Sep;62(9):3604-7 - PubMed
  51. EMBO J. 1984 Jun;3(6):1429-34 - PubMed

Substances

MeSH terms

Publication Types